Skip to main content
. Author manuscript; available in PMC: 2024 Dec 2.
Published in final edited form as: Ann Surg. 2022 Jun 27;276(3):430–440. doi: 10.1097/SLA.0000000000005554

Table 4.

Multinomial regression models of individual-level and contextual-level measures associated with breast cancer subtype

Models Subtype* Model
Outputs		 Age Stage** Ancestry nSES***
II III IV African /
European		 Native
American /
European		 East
Asian /
European		 2 3
Age + Stage ER+/HER2+ OR 0.998 2.519 3.522 2.036
P 0.873 0.041 0.013 0.539
95% CI 0.968-1.027 1.04-6.104 1.3-9.535 0.211-19.668
ER−/HER2+ OR 0.763 3.019 9.125 17.116
P 0.238 0.185 0.007 0.010
95% CI 0.931-1.018 0.588-15.487 1.835-45.422 1.95-150.355
TNBC OR 1.014 5.669 9.855 0.000
P 0.307 0.001 <0.001 0.986
95% CI 0.987-1.042 2.067-15.534 3.35-28.991 0- >100
Age + Stage + nSES ER+/HER2+ OR 0.998 2.497 3.655 1.904 2.440 1.723
P 0.871 0.043 0.011 0.581 0.129 0.379
95% CI 0.969-1.027 1.027-6.068 1.347-9.954 0.194-18.728 0.771-7.721 0.589-2.974
ER−/HER2+ OR 0.972 2.983 8.390 21.073 0.264 0.665
P 0.223 0.193 0.010 0.008 0.053 0.483
95% CI 0.93-1.017 0.576-15.456 1.667-42.224 2.223-199.737 0.069-1.016 0.213-2.079
TNBC OR 1.017 6.038 9.507 0.000 0.348 0.343
P 0.229 0.001 <0.001 0.982 0.011 0.011
95% CI 0.989-1.046 1.08-16.81 3.177-28.446 0- >100 0.154-0.789 0.151-0.781
Age + Stage + Ancestry ER+/HER2+ OR 0.996 2.524 3.327 2.036 0.992 1.338 1.069
P 0.080 0.041 0.020 0.540 0.873 0.382 0.228
95% CI 0.967-1.026 1.037-6.147 1.204-9.198 0.21-19.767 0.897-1.097 0.696-2.57 0.959-1.194
ER−/HER2+ OR 0.969 3.736 10.299 26.076 1.100 1.533 1.120
P 0.193 0.150 0.011 0.006 0.006 0.301 0.052
95% CI 0.924-1.016 0.621-22.466 1.707-62.178 2.54-268.003 1.027-1.177 0.682-3.442 0.999-1.256
TNBC OR 1.015 5.795 10.054 0.000 1.062 1.057 0.997
P 0.278 0.001 <0.001 0.984 0.046 0.873 0.976
95% CI 0.988-1.043 2.071-16.216 3.33-30.326 0- >100 1.001-1.126 0.537-2.077 0.811-1.225
Age + Stage + Ancestry + nSES ER+/HER2+ OR 0.995 2.489 3.391 1.954 0.999 1.539 1.067 2.829 2.059
P 0.752 0.046 0.019 0.566 0.994 0.208 0.239 0.090 0.251
95% CI 0.966-1.106 1.017-6.092 1.218-9.44 0.199-19.221 0.903-1.106 0.787-3.007 0.958-1.19 0.85-9.507 0.601-7.05
ER−/HER2+ OR 0.969 3.490 9.459 29.964 1.091 1.275 1.115 0.320 0.736
P 0.191 0.173 0.015 0.005 0.015 0.581 0.067 0.118 0.627
95% CI 0.923-1.016 0.577-21.115 1.56-57.34 2.779-323.112 1.017-1.169 0.537-3.028 0.992-1.255 0.077-1.332 0.215-2.524
TNBC OR 1.018 6.135 9.905 0.000 1.049 0.896 1.006 0.366 0.366
P 0.213 0.001 <0.001 0.980 0.120 0.755 0.951 0.019 0.019
95% CI 0.99-1.046 2.166-17.392 3.235-30.356 0- >100 0.987-1.116 0.448-1.793 0.82-1.236 0.158-0.848 0.158-0.850
*

Reference ER+/HER2−

**

Reference Stage 1

***

Reference nSES 1: nSES 1: <$35,600, nSES 2: $35,600-55,600, nSES 3: > $55,600